AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2017
Apr 5, 2017
34395_dirs_2017-04-05_415a5d42-27d0-4bf0-841a-f42967713a83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-04-03
Reporting Person: Faulkes Martin Charles (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-04-03 | Common Stock | X | 58034 | $2.6 | Acquired | 1351284 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-04-03 | Warrant (Right to Buy) | $2.6 | X | 58034 | Disposed | 2017-05-10 | Common Stock (58034) | Direct |
More from VOLITIONRX LTD
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 9
Capital/Financing Update
2026
Jun 5
Proxy Solicitation & Information Statement
2026
Jun 2
Capital/Financing Update
2026
May 22
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Report Publication Announcement
2026
May 14
Proxy Solicitation & Information Statement
2026
May 13
Annual Report
2026
Apr 30